Arax Advisory Partners’s AMN Healthcare AMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$174K Buy
5,361
+5,235
+4,155% +$135K ﹤0.01% 2350
2026
Q1
$2.36K Buy
126
+108
+600% +$2.05K ﹤0.01% 3062
2025
Q4
$284 Sell
18
-3,477
-99% -$62.1K ﹤0.01% 3682
2025
Q3
$67.7K Buy
3,495
+3,343
+2,199% +$65.3K ﹤0.01% 1695
2025
Q2
$3.14K Buy
152
+89
+141% +$1.85K ﹤0.01% 2409
2025
Q1
$1.54K Buy
+63
New +$1.62K ﹤0.01% 2159

Other funds holding AMN

Arax Advisory Partners's AMN Position: Q2 2026 in Review

Arax Advisory Partners increased its AMN Healthcare (AMN) stake by 4,155% in Q2 2026, buying an estimated $135K and bringing the position to 5,361 shares worth $174K. The position accounts for ﹤0.01% of the portfolio, ranked #2350.

Arax Advisory Partners first reported a position in AMN in Q1 2025 and has held it in 6 quarters since. 284 funds tracked by Wall St. Rank hold AMN as of Q2 2026.

  • Arax Advisory Partners held 5,361 shares of AMN Healthcare worth $174K as of Q2 2026.
  • Arax Advisory Partners bought 5,235 AMN Healthcare shares in Q2 2026, an estimated $135K.
  • AMN Healthcare made up ﹤0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #2350 holding.
  • Arax Advisory Partners first reported a position in AMN Healthcare in Q1 2025 and has held it in 6 quarters since.
  • 284 funds tracked by Wall St. Rank held AMN Healthcare as of Q2 2026.

Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.